The store will not work correctly when cookies are disabled.
N-(3-Aminopropyl)[3-(4-Fluorophenyl)(1H-Indazol-5-yl)]Carboxamide
ID: ALA3986679
PubChem CID: 22479969
Max Phase: Preclinical
Molecular Formula: C17H17FN4O
Molecular Weight: 312.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NCCCNC(=O)c1ccc2[nH]nc(-c3ccc(F)cc3)c2c1
Standard InChI: InChI=1S/C17H17FN4O/c18-13-5-2-11(3-6-13)16-14-10-12(4-7-15(14)21-22-16)17(23)20-9-1-8-19/h2-7,10H,1,8-9,19H2,(H,20,23)(H,21,22)
Standard InChI Key: MIXVCLBTONMNTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
16.8748 -8.2874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8737 -9.1070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5817 -9.5159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5799 -7.8786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2886 -8.2838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2933 -9.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0734 -9.3509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5507 -8.6858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0656 -8.0264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3291 -10.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7841 -10.7324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0406 -11.5075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8417 -11.6734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3858 -11.0580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1264 -10.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0997 -12.4488 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.1656 -9.5150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4583 -9.1059 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1650 -10.3322 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7502 -9.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0428 -9.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3348 -9.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6274 -9.1036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
13 16 1 0
2 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.35 | Molecular Weight (Monoisotopic): 312.1386 | AlogP: 2.45 | #Rotatable Bonds: 5 |
Polar Surface Area: 83.80 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.58 | CX Basic pKa: 9.77 | CX LogP: 1.81 | CX LogD: -0.48 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: -1.39 |
References
1. (2002) Indazole derivatives as JNK inhibitors and compositions and methods related thereto, |